Lankenau Institute for Medical Research

Devoted to advancing new approaches to the most difficult medical challenges

Featured Clinical Research

Participants in clinical trials gain access to the highest level of care and monitoring possible.

Researchers at Main Line Health seek patients who have previously been treated for non-small cell lung cancer to participate in the Lung-MAP screening study.

Learn more about this study

At the forefront of cancer research

Cancer research delves broadly into many aspects of biomedical science. Our work in this diverse field focuses on developing new methods to improve diagnosis and treatment of the most common and deadly cancers.

Explore cancer research

Developing new drugs and devices for cardiovascular disease

Cardiovascular disease is the most prominent killer in the United States after cancer. Our work focuses on new drugs and devices to correct heart beat disorders, treat and prevent heart attacks and strokes, and avert heart failure.

Learn about cardiovascular research

Gaining a more intimate understanding of clinical issues

We also investigate autoimmune disorders, regenerative medicine, infectious disease, neurological and gastrointestinal disorders, as well as population health—all with the goal of improving patients’ health and well-being.

Explore additional research efforts

Featured Researcher

Melvin Reichman, PhD

Senior Investigator and Director, LIMR Chemical Genomics Center

Dr. Reichman’s research interests include understanding how protein misfolding leads to neurodegeneration in amyotrophic lateral sclerosis and discovering combination-drug treatment; applying high throughput screening to discover fructosamine-3-kinase inhibitors to treat diabetes complications; developing and applying new screening technologies to discover novel combination drugs; and public-private partnering in pharmaceutical R&D.

Learn more about Dr. Melvin Reichman

View more research news

Patient Spotlight

Taking research to heart

Through the Lankenau Institute for Medical Research, Main Line Health patients have access to groundbreaking cardiac clinical trials. Read More
Patient Spotlight

‘Trials’ and tribulations: One cancer survivor’s story

“Whenever I look through my patient list for that day, if we’re at a crossroads, my first thought is, is there a good and appropriate standard treatment, or should we consider a clinical trial.” Read More

Lankenau Institute for Medical Research

Featured Clinical Research

At the forefront of cancer research

Developing new drugs and devices for cardiovascular disease

Gaining a more intimate understanding of clinical issues

Featured Researcher

Melvin Reichman, PhD

Latest research news

Main Line Health honors Colorectal Cancer Awareness Month with focus on research

Lankenau Institute for Medical Research contracts with L2C Partners to manage and commercialize inventions in biomedicine and health care

New approach to treat retinal diseases that cause blindness has been suggested by studies at Lankenau Institute for Medical Research

Main Line Health tops list of enrollment sites for one arm of peripheral artery disease treatment study

Researchers from the Lankenau Institute for Medical Research uncover potential new therapy for ulcerative colitis

Main Line Health system chief of cardiovascular disease serves as co-lead on international clinical trial for patients with peripheral artery disease

Patient Spotlight

Taking research to heart

Patient Spotlight

‘Trials’ and tribulations: One cancer survivor’s story